xercise-based cardiac rehabilitation (CR) improves functional capacity and reduces mortality in patients with acute myocardial infarction (AMI). 1-3 Although the exact mechanisms by which exercise reduces mortality are unclear, one of the definite effects is improving exercise tolerance. 4, 5 Exercise tolerance itself is a multifactorial phenotype influenced by several genetic and environmental factors and the training benefits may be attributed predominantly to adaptations in the peripheral circulation and skeletal muscles rather than to adaptations in cardiac performance. 6 However, the precise mechanism is not fully understood.
hypertrophy, cardiomyopathy and restenosis after percutaneous transluminal coronary angioplasty remain quite controversial.
Several studies have shown that the ACE I allele is associated with enhanced physical performance. An increased frequency of the ACE I allele has been reported in army recruits, rowers, and high altitude mountaineers. 9, 10 The ACE I allele has been associated with higher peak oxygen consumption (PV • O2) levels in postmenopausal women. 11 Moreover, a recent study has demonstrated an association of the ACE DD genotype with decreased exercise tolerance in 57 patients with CHF. 12 However, the association between ACE genotype and exercise capacity or the effect of exercise training in patients after AMI with or without LV dysfunction remains unknown. Accordingly, in the current study, we examined exercise capacity in relation to ACE polymorphism in patients with AMI participating in CR for 3 months.
week: 2-3 times in hospital under supervision and the remaining 2-3 times at home. Exercise consisted of aerobic dance and stationary bicycle riding in hospital and brisk walking at home. The training heart rate (HR) was determined according to the HR reserve method or Karvonen's equation (k =0.5-0.6): training HR = (peak HR -rest HR) × k + rest HR, where peak and rest HR were obtained in a symptom-limited exercise test at the beginning of the program. 13 Six patients failed to complete the 3-month CR program and so the total number of subjects was 162.
Cardiopulmonary Exercise Testing (CPX)
All patients underwent symptom-limited incremental CPX on a bicycle ergometer at the beginning and end of the 3-month CR program. Breath-by-breath respiratory gas exchange measurements were performed using a computerized metabolic cart (Minato Products, Japan). Details of the test protocol have been published elsewhere. 14 
Assessment of LV Systolic Function
LV ejection fraction (LVEF) was determined as an index of LV systolic function by contrast left ventriculography at the beginning of the CR program (approximately 3 weeks after AMI onset). LVEF <45% was considered as LV dysfunction.
Blood Tests
Genomic DNA was isolated from peripheral leukocytes as previously reported. 15 The ACE genotypes were determined by polymerase chain reaction as previously reported. 15 The institutional ethics committee approved the study and written informed consent was obtained from each patient before participation.
Statistics
The ANOVA method was used to assess the statistical significance of differences in means across genotype groups. All data are expressed as the mean value ± SD. A p-value <0.05 was considered significant. All statistical analyses were performed with the JMP statistical package (SAS Institute Inc, Cary, NC, USA).
Results

Patient Characteristics
The 168 patients were divided into 3 groups according to their ACE genotype, the frequencies of which were in a Hardy-Weinberg equilibrium in this population. Baseline characteristics of the 3 groups are summarized in Table 1 . Sex, mean age, body weight, body mass index and risk factors did not differ significantly among the genotypes. No significant difference in either resting LVEF or HR was detected. Although the subjects with the DD genotype had a trend toward a lower percentage of -blocker treatment, no significant difference was observed. Fig 1 shows the effects of 3-month CR on the CPX parameters in all subjects. The peak work rate (PWR), PV
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• O2 and the slope of the minute ventilation -carbon dioxide production relationship (V • E/V • CO2 slope) improved significantly after 3 months of CR (12.1%, 13.3%, -3.9% from baseline, respectively). Table 2 shows the CPX data at the beginning and end of the 3-month CR stratified by the ACE genotype. It also shows the increase rate ((end -beginning)/beginning ×100; %). No significant differences in PWR, PV
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• O2 or V • E/V • CO2 slope were observed among the 3 genotype groups at either time point. All parameters improved by a similar magnitude across the genotypes after 3-month CR as demonstrated by the increase rate.
Subanalysis was performed in patients with LV dysfunction (LVEF <45%, n=60), which is shown in Table 3 . The pattern of the genotype distributions did not differ significantly between the patients with or without LV dysfunction (chi-square test, p=0.269). No significant differences in the 3 exercise parameters were observed among the 3 genotype groups at either the beginning or the end. Also, there were no significant differences in the increase rate of the 3 parameters among the 3 groups. Similar results were obtained in the subanalysis of male patients (63II/54ID/22DD) (data not shown).
Discussion
In the present study, based upon the hypothesis that the ACE genotype may have an association with the exercise capacity, we investigated this association in patients with AMI participating in CR for 3 months. However, we found no association between ACE I/D polymorphism and exercise capacity in this patient group, even in those with LV dysfunction. Furthermore, the ACE genotype may have no influence on the training effects of CR after AMI. Although many studies have explored the relationship of ACE geno- type with the exercise capacity or training effects in athletes or healthy persons, this is the first study to examine the association between them in patients after AMI. In particular, because CR obviously provides improved exercise tolerance and quality of life and decreased mortality in patients with CHF or after AMI, it is important to clarify whether it is genetic factors, such as the ACE genotype, that are causing the training effects of CR.
The ACE genotype affects both serum and tissue ACE levels and many studies have investigated the associations with various cardiovascular diseases. As ACE is involved in the metabolism of substances that affect vascular and cardiac remodeling, it may account for the cardiopulmonary fitness of individuals and for the differences among individuals in response to physical training. Recent studies have shown higher frequencies of the ACE I allele among endurance athletes compared with non-athlete controls. 9, 10 Moreover, Hangberg et al reported an association between the ACE I allele and higher PV
• O2 levels in postmenopausal women. 11 However, there also have been conflicting reports about this association. Some studies failed to find an association between the ACE I allele and exercise capacity and did not support the hypothesis that ACE I/D polymorphism plays a major role in cardiopulmonary endurance. 16 Others reported that the ACE DD allele is associated with higher levels of PV
• O2 and that a greater strength gain in cardiac and skeletal muscles in response to resistance training program is found in the D allele carriers. 17, 18 The present study demonstrated that in post-AMI patients, the ACE genotype did not affect either the baseline exercise capacity or the training effects of a 3-month CR program, and there are several possible explanations. The subjects investigated were not healthy and the intensity of the exercise training was much less than that of endurance training in athletes. It is also well known that ethnic differences can affect genetic associations. However, at present, a physiological explanation for any association between the cardiorespiratory phenotype and ACE polymorphism has not been found and requires further investigation.
Recently, Abraham et al reported an association of the ACE DD genotype with decreased exercise tolerance 57 patients with CHF. 12 They observed that those with the ACE DD genotype had more restrictive pulmonary changes and a reduced lung diffusing capacity, and they attributed this to the poorer exercise capacity in the patients with CHF. Huwang et al reported that the ACE DD genotype might be a marker of a more severe condition in Chinese Han patients with CHF. 19 However, it remains controversial whether ACE polymorphism is associated with CHF. 20 In a subanalysis of the present study, we demonstrated no impact of ACE I/D polymorphism on exercise capacity in patients with LV dysfunction after AMI. As we did not assess the pulmonary function, we could not confirm Abraham's observations precisely in the current study. Also, we defined LV dysfunction as LVEF <45% and Abraham et al used LVEF <35%, which might explain the different results between the 2 studies. Exercise tolerance is a multifactorial phenotype and training benefits may be attributed to adaptations in cardiac and pulmonary performances, as well as those in the peripheral circulation and skeletal muscles. Although ACE I/D polymorphism does not appear to bean important modulator of the exercise capacity of patients with LV dysfunction after AMI, further studies are necessary to clarify the contribution of other important genetic factors in the decreased exercise capacity of CHF/LV dysfunction patients.
Study Limitations
We did not assess the effect of genotype on circulating markers of the renin -angiotensin system. However, because the association of the ACE D allele with increased plasma ACE activity has been consistently demonstrated in many previous studies, our observation suggests there is no relationship between plasma ACE activity and exercise capacity. In addition, the analysis and findings of this study are limited by the retrospective design. Finally, the study population was relatively small, especially in the subanalysis of patients with LV dysfunction. Any negative finding could thus be caused by a low statistical power. A larger study will be required if associations of the ACE genotype are to be investigated further.
